PANDORA S9 BIDCO LIMITED

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  —

  Not reported

• Cash

  —

  Not reported

• Net assets

  -49.5%

  -£21,293,541 → -£31,828,352

• Employees

  +75%

  4 → 7

• Operating profit

  -38.1%

  -£342,543 → -£473,137

• Profit before tax

  -29.3%

  -£8,144,597 → -£10,534,811

• Wages

  +4.7%

  £981,131 → £1,026,978

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

Azets Audit Services Limited

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The company continues to be in a net liabilities position as of the financial year ended 31 March 2025, with net liabilities totalling 31,828,352 (2024 - 21,293,541), which may raise doubts about the group's ability to continue as a going concern. ... the directors are confident that the business is a going concern and has the ability to meet its liabilities as they fall due and therefore believe it is appropriate to prepare the financial statements on a going concern basis”

Group structure

1. PANDORA S9 BIDCO LIMITED · parent
   1. Preventx Holdings Limited 100% · United Kingdom · Holding company
   2. Preventx Limited 100% · United Kingdom · Provision of sexual health screening
   3. Vira Services BV 100% · Netherlands · Provision of sexual health screening
   4. Directlab BV 100% · Netherlands · Provision of sexual health screening

Significant events

• “On 2nd February 2024, the group announced its intention to divest of its European entity, Centro Medico Openhouse S L U, incorporated in Spain The provision represents the legal fees of Pandora S9 Bidco Limited and Centro Medico Openhouse S L U in an agreement to pay the legal fees of both parties”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

12

last 12 months

Capital events

0

last 24 months

Officers appointed

1

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.